Regulatory & Compliance

How Is Stryker Recovering From the Global Cyberattack?
Regulatory & Compliance How Is Stryker Recovering From the Global Cyberattack?

The digital pulse of modern medicine recently skipped a beat when one of the world's most prominent surgical technology providers faced an unprecedented breach of its corporate infrastructure. This event highlighted how the MedTech industry serves as the backbone of global healthcare, where any

Cyberattacks Pose Growing Threat to African Healthcare Systems
Regulatory & Compliance Cyberattacks Pose Growing Threat to African Healthcare Systems

The sudden convergence of advanced medical diagnostics and digital patient management has created an unprecedented environment where the promise of better health outcomes is shadowed by a persistent and evolving technological menace. Across the African continent, healthcare providers are

Adverse Event Monitoring System – Review
Regulatory & Compliance Adverse Event Monitoring System – Review

The rapid acceleration of medical innovation often outpaces the bureaucratic systems tasked with ensuring that new treatments do not cause unintended harm to the very public they aim to protect. For decades, the Food and Drug Administration struggled with a fragmented infrastructure that

How Did a Cyberattack Wipe Out Stryker’s Global Operations?
Regulatory & Compliance How Did a Cyberattack Wipe Out Stryker’s Global Operations?

The sudden and total collapse of the digital infrastructure at one of the world's most prominent medical technology firms has sent shockwaves through the global healthcare supply chain this week. Stryker, a Fortune 500 leader responsible for critical surgical equipment and medical devices, found

How Did Intuitive Protect Its Robots From a Cyberattack?
Regulatory & Compliance How Did Intuitive Protect Its Robots From a Cyberattack?

The realization that a single misplaced click by one employee could potentially compromise the sophisticated digital infrastructure of a global leader in robotic-assisted surgery highlights the precarious nature of modern healthcare cybersecurity in the current digital landscape. While the industry

FDA Reverses Course to Review Moderna mRNA Flu Vaccine
Regulatory & Compliance FDA Reverses Course to Review Moderna mRNA Flu Vaccine

The landscape of immunization technology has shifted dramatically as the Food and Drug Administration recently opted to reconsider the biologics license application for Moderna’s experimental messenger RNA influenza vaccine. This unexpected regulatory pivot followed a high-stakes Type A meeting

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later